Sembragiline is a MAO-B inhibitor potentially for the treatment of Alzheimer's disease (AD). References: Sturm S, Forsberg A, Nave S, Stenkrona P, Seneca N, Varrone A, Comley RA, Fazio P, Jamois C, Nakao R, Ejduk Z, Al-Tawil N, Akenine U, Halldin C, Andreasen N, Ricci B. Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):382-391. doi: 10.1007/s00259-016-3510-6. PubMed PMID: 27633250; PubMed Central PMCID: PMC5281649.

纯度：≥98%

CAS：676479-06-4